Istituto Superiore di Sanità

Pubblicazioni

1. Suligoi B, Rodella A, Raimondo M, Regine V, Terlenghi L, Manca N, Casari S, Camoni L, Salfa MC, Galli C. Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. Journal of clinical microbiology 2011;49(7):2610-2613.
   
2. Camoni L, Federico B, Capelli G, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B, SERT Study Group. Few Italian drug users undergo HIV testing. AIDS and behavior 2011;15(4):711-717.
   
3. Camoni L, Dal Conte I, Regine V, Colucci A, Chiriotto M, Vullo V, Sebastiani M, Cordier L, Beretta R, Fiore JR, Tateo M, Affronti M, Cassarà G, Suligoi B. Sexual behaviour reported by a sample of Italian MSM before and after HIV diagnosis. Annali dell'Istituto Superiore di Sanità 2011;47(02):214-219.
   
4. Tavoschi L, Bernasconi D, Chiappi M, Suligoi B, Galli C, Regine V, Kityo C, Buttò S. Performance of V3-based HIV-1 sero subtyping in HIV endemic areas. Annali dell'Istituto Superiore di Sanità 2011;47(04):424-428.
   
5. Bernasconi D, Tavoschi L, Regine V, Raimondo M, Gama D, Sulgencio L, Almaviva M, Galli C, Ensoli B, Suligoi B, Sukati H, Buttò S. Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland. Journal of clinical virology 2010;48(3):180-183.
   
6. Suligoi B, Raimondo M, Regine V, Salfa MC, Camoni L. Epidemiology of human immunodeficiency virus infection in blood donations in Europe and Italy. Blood transfusion 2010;8(3):178-185.
   
7. Riva C, Caramma I, Lai A, Corvasce S, Violin M, Dehò L, Prati F, Colombo MC, Capetti A, Franzetti M, Rossini V, Tambussi G, Ciccozzi M, Suligoi B, Mussini C, Rezza G, Balotta C. Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients of the 1992 to 2005 in Italy. AIDS research and human retroviruses 2010;26(1):41-49.
   
8. Serraino D, De Paoli A, Zucchetto A, Pennazza S, Bruzzone S, Spina M, De Paoli P, Rezza G, Dal Maso L, Suligoi B. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era. Cancer epidemiology 2010;34(3):257-261.
   
9. Buttò S, Raimondo M, Fanales BE, Suligoi B. Suggested strategies for the laboratory diagnosis of HIV infection in Italy. Annali dell'Istituto Superiore di Sanità 2010;46(01):34-41.
   
10. Buttò S, Suligoi B, Fanales BE, Raimondo M. Laboratory diagnostics for HIV infection. Annali dell'Istituto Superiore di Sanità 2010;46(01):24-33.
    
11. Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B. Continued high prevalence of HIV, HBV and HCV among injecting and non injecting drug users in Italy. Annali dell'Istituto Superiore di Sanità 2010;46(01):59-65.
    
12. Fanales BE, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Annali dell'Istituto Superiore di Sanità 2010;46(01):5-14.
    
13. Suligoi B, Raimondo M, Fanales BE, Buttò S. The epidemic of HIV infection and AIDS, promotion of testing, and innovative strategies. Annali dell'Istituto Superiore di Sanità 2010;46(01):15-23.
    
14. Raimondo M, Dorrucci M, Camoni L, Regine V, Salfa MC, Vescio MF, Suligoi B. A review of the HIV epidemic in Europe. European infectious disease 2010;4(2):22-25.
    
15. Serraino D, Bruzzone S, Zucchetto A, Suligoi B, De Paoli A, Pennazza S, Camoni L, Dal Maso L, De Paoli P, Rezza G. Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases. AIDS research and therapy 2010;7:11.
    
16. Dal Maso L, Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al, Suligoi B, Cancer and AIDS Registry Linkage (CARL) Study. Pattern of cancer risk in person with AIDS in Italy in the HAART era. British journal of cancer 2009;100(5):840-847.
    
17. Serraino D, Zucchetto A, Suligoi B, Bruzzone S, Camoni L, Boros S, De Paoli A, Dal Maso L, Franceschi S, Rezza G. Survival after AIDS in Italy, 1999-2006: a population-based study. JAIDS-Journal of acquired immune deficiency syndromes 2009;52(1):99-105.
    
18. Camoni L, Regine V, Colucci A, Dal Conte I, Chiriotto M, Vullo V, Sebastiani M, Cordier L, Beretta R, Fiore JR, Tateo M, Affronti M, Cassarà G, Suligoi B. Changes in at-risk behavior for HIV Infection among HIV-positive persons in Italy. AIDS patient care and STDs 2009;23(10):853-858.
    
19. Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B, SERT Study Group. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitic C virus among drug users in Italy: A cross-sectional study. Scandinavian journal of infectious diseases 2009;41(6-7):520-523.
    
20. Suligoi B, Quaglio G, Regine V, Ramadani N, Bertinato L, Cami A, Dentico P, Volpe A, Figliomeni M, Camoni L, Putoto G, Rezza G. Seroprevalence of HIV, HSV-2, and Treponema pallidum in the Kosovarian population. Scandinavian journal of infectious diseases 2009;41(8):608-613.
    
21. Starnino S, Suligoi B, Regine V, Bilek N, Stefanelli P, Neisseria gonorrhoeae Italian Study Group. Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. Clinical microbiology and infection 2008;14(10):949-954.
    
22. Suligoi B, Buttò S, Galli C, Bernasconi D, Robert AS, Tavoschi L, Chiappi M, Mugyenyi P, Pimpinelli F, Kityo C, Regine V, Rezza G. Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. Journal of clinical virology 2008;41(4):288-292.
    
23. Longo B, Novati S, Montieri S, Pontali E, Taglia F, Leo G, Babudieri S, Starnini G, Monarca R, Suligoi B, Rezza G, Ciccozzi M, Italian Study Group on HIV in Prisons (ISGHP). HIV-1 diversity among inmates of Italian prisons. Journal of medical virology 2008;80(10):1689-1694.
    
24. Longo B, Camoni L, Boros S, Suligoi B. Increasing proportion of AIDS diagnoses among older adults in Italy. AIDS patient care and STDs 2008;22(5):365-371.
    
25. Camoni L, Salfa MC, Regine V, Pasqualini P, Borghi V, Icardi G, Curtale F, Ferro A, Suligoi B. HIV incidence estimate among non-nationals in Italy. European journal of epidemiology 2007;22(11):813-817.
    
26. Franceschi S, Dal Maso L, Suligoi B, Rezza G. Evidence for lack of cervical cancer screening among HIV positive women in Italy [letter]. European journal of cancer prevention 2006;15(6):554-556.
    
27. Martrò E, Suligoi B, Gonzalez V, Bossi V, Esteve A, Mei J, Vicenc A, The Recent HIV infection study group. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. Journal of clinical microbiology 2005;43(12):6197-6199.
    
28. Suligoi B, Wagner T, Ciccozzi M, Rezza G. The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. Vaccine 2005;23(12):1437-1445.
    
29. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Journal of medical virology 2005;76(3):311-317.
    
30. Suligoi B, Danaya RT, Sarmati L, Owen IL, Boros S, Pozio E, Andreoni M, Rezza G. Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. American journal of tropical medicine and hygiene 2005;72(1):33-36.
    
31. Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli M, Sinicco A, Giuliani M, Vlahov D, Pezzotti P, Rezza G, The Italian HIV-Seroconversion Study. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. AIDS 2004;18(17):2313-2318.
    
32. Suligoi B, Magliocchetti N, Nicoletti G, Pezzotti P, Rezza G. Trends in HIV prevalence among drug-users attending public drug treatment centres in Italy; 1990-2000. Journal of medical virology 2004;73(1):1-6.
    
33. Volpi A, Sarmati L, Suligoi B, Montano M, Rezza G, Andreoni M. Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. Journal of medical virology 2004;74(3):467-472.
    
34. Giuliani M, Suligoi B, Italian STI Surveillance Working Group. Differences between nonnational and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections. Sexually transmitted diseases 2004;31(2):79-84.
    
35. Suligoi B, Massi M, Galli C, Sciandra M, Di Sora F, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. JAIDS-Journal of acquired immune deficiency syndromes 2003;32(4):424-8.
    
36. Suligoi B, Dorrucci M, Uccella I, Andreoni M, Rezza G, Italian Seroconversion Study. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV-seroconverters. Journal of medical virology 2003;69(2):182-187.
    
37. Sarmati L, Andreoni M, Suligoi B, Bugarini R, Uccella I, Pozio E, Rezza G. Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. American journal of tropical medicine and hygiene 2003;68(4):501-502.
    
38. Fiore JR, Suligoi B, Monno L, Angarano G, Pastore G. HIV-1 shedding in genital tract of infected women [letter]. Lancet 2002;359(9316):1525-1526.
    
39. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Rezza G, Italian Seroconversion Study Group. No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2-HIV-infected individuals. Antiviral therapy 2002;7(4):289-291.
    
40. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. Journal of clinical microbiology 2002;40(11):4015-20.
    
41. Suligoi B, Calistri A, Cusini M, Palù G, Italian Herpes Management Forum. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy. Journal of medical virology 2002;67(3):345-348.
    
42. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Zerboni R, Rezza G, Italian Seroconversion Study Group. Prevalence and determinants of Herpes simplex virus type 2 infection in a cohort of HIV-positive individuals in Italy. Sexually transmitted diseases 2002;29(11):665-667.
    
43. Volpi A, Gentile G, Pica F, Suligoi B. Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study. Pediatric infectious disease journal 2002;21(8):739-743.
    
44. Suligoi B, Dorrucci M, Volpi A, Andreoni M, Pezzotti P, Rezza G, Italian Seroconversion Study. Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion. AIDS 2001;15(1):133-135.
    
45. Rezza G, Danaya RT, Wagner T, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E. Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerging infectious diseases 2001;7(5):893-895.
    
46. Suligoi B, Tchangmena Befeuka O, Sarmati L, Bugarini R, Toma L, Bakary KD, Glikoutou M, Rezza G. Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in northern Cameroon. Sexually transmitted diseases 2001;28(12):690-693.
    
47. Dorrucci M, Suligoi B, Serraino D, Tirelli U, Rezza G, The Italian HIV-Seroconversion Study. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. JAIDS-Journal of acquired immune deficiency syndromes 2001;26(4):377-380.
    
48. Suligoi B, Cusan M, Santopadre P, Palù G, Catania S, Girelli G, Pala S, Vullo V, Italian Herpes Management Forum. HSV-2 specific seroprevalence among various populations in Rome, Italy. Sexually transmitted infections 2000;76(3):213-214.
    
49. Suligoi B, Galli C, Ciuta S, Decker R, Study group for HTLV and STDs. Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Study Group for HTLV and STDs. European journal of epidemiology 1999;15(3):225-229.
    
50. Suligoi B, Giuliani M, Galai N, Balducci M. HIV incidence among repeat HIV testers with sexually transmitted diseases in Italy. AIDS 1999;13(7):845-850.
    
51. Giuliani M, Suligoi B. Sentinel surveillance of sexually transmitted diseases in Italy. Euro surveillance 1998;3(6):55-58.
    
52. Suligoi B, Rezza G. Convegno nazionale: Infezioni da HTLV I-II. Roma: Istituto Superiore di Sanità; 1998. (Rapporti ISTISAN 98/29).
    
53. Suligoi B, Von Hunolstein C, Scopetti F, Pataracchia M, Greco D. Surveillance of systemic invasive disease caused by group A Streptococcus in Italy, 1994-1996. Euro surveillance 1998;3(2):11-14.
    
54. Suligoi B, Giuliani M, Migration medicine study gro p. Sexually transmitted diseases among foreigners in Italy. Epidemiology and infection 1997;118(3):235-241.
    
55. Suligoi B. The natural history of human immunodeficiency virus infection among women as compared with men. Sexually transmitted diseases 1997;24(2):77-83.
    
56. Suligoi B, Giuliani M, Binkin N. The national STD surveillance system in Italy: results of the first year of activity. International journal of STD and AIDS 1994;5(2):93-100.
    

Il contenuto di questa pagina mi è stato utile  + ++ +++ ++++ +++++